Selling, General, and Administrative Costs: Johnson & Johnson vs Opthea Limited

A Tale of Two Companies: SG&A Expenses Over Time

In the world of corporate finance, Selling, General, and Administrative (SG&A) expenses are a crucial indicator of a company's operational efficiency. This chart compares the SG&A expenses of two distinct companies: Johnson & Johnson, a global healthcare giant, and Opthea Limited, a smaller biotech firm, from 2014 to 2023.

Johnson & Johnson's SG&A expenses have shown remarkable stability, averaging around $21 billion annually, with a slight dip in 2022. This consistency reflects their robust operational strategies and market presence. In contrast, Opthea Limited's expenses have surged by over 1,500% from 2014 to 2023, highlighting their aggressive growth and expansion efforts in the biotech sector.

While Johnson & Johnson's expenses dwarf those of Opthea, the latter's rapid increase signals a dynamic shift in their business model. This comparison underscores the diverse strategies companies employ to navigate their respective industries.